ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

June 27, 2014

NCAB Says Restrictions on Animal Research Threatens Progress

May 20, 1988

Cooperative Group Competing Renewals May Be Funded Only at 70-80% Of Amounts Recommended By CCIRC

January 2, 1981

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996

Large Pregnancy Weight Gain Raises Risk For Breast Cancer

May 31, 2002

FDA Orders More Changes In ESA Label,

August 8, 2008